Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial

Cho, BC; Kim, DW; Spira, AI; Gomez, JE; Haura, EB; Kim, SW; Sanborn, RE; Cho, EK; Lee, KH; Minchom, A; Lee, JS; Han, JY; Nagasaka, M; Sabari, JK; Ou, SHI; Lorenzini, P; Bauml, JM; Curtin, JC; Roshak, A; Gao, GC; Xie, JH; Thayu, M; Knoblauch, RE; Park, K

Cho, BC (通讯作者)，Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Coll Med, Seoul, South Korea.

NATURE MEDICINE, 2023; 29 (10): 2577

Abstract

Patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) often develop resistance to current standard third-ge......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索